Stellar Biotechnologies Publishes New Corporate Profile
13 mars 2012 09h00 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Mar 13, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) announced today that the Company has published an...
Stellar Biotechnologies Announces Receipt of Lead Purchase Order
20 sept. 2011 09h10 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Sep 20, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce they have received the first purchase order from...
Stellar Biotechnologies Awarded $498,560 Phase IIB National Science Foundation (NSF) Grant
29 août 2011 16h05 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Aug 29, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that the National Science Foundation (NSF) has...
Stellar Biotechnologies Announces Pre-IDE Meeting With FDA
10 mai 2011 09h45 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - May 10, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces the completion of a pre-Investigational Device Exemption (pre-IDE) meeting...
Stellar Biotechnologies Appoints Vice President, Business Development & Marketing
08 mars 2011 08h55 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - March 8, 2011) - Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) has appointed Michael R. McClurg to VP, Business Development & Marketing. His...